Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Return on Sales [ROS] (2018 - 2026)

Updated

Regenerative Medical Technology's Return on Sales [ROS] was 14.07% in Q2 2026, up 39.50 percentage points from -25.43% a year earlier and up 5.36 percentage points from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regenerative Medical Technology's Return on Sales [ROS] was 0.46% through Jun 30, 2026, down 5.42 percentage points year-over-year; for FY2025, it came in at -17.00%, down 18.98 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of +797.09 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was 1.98% in FY2024 (+31.65 pp), -29.68% in FY2023 (+47.75 pp), -77.43% in FY2022 (+2187.89 pp) and -2265.32% in FY2021 (-1451.23 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] since Q4 2024.
  • Compared with a year earlier, Return on Sales [ROS] was higher in five of the last eight quarters, with an average year-over-year change of +4.87 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q3 2022 (a gain of 5418.52 percentage points); the worst was Q3 2021 (a drop of 5066.37 percentage points).
  • Per Business Quant data, RMTG's Return on Sales [ROS] in the three quarters before Q2 2026 was 8.71% (Q1 2026), -19.48% (Q4 2025) and -37.76% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn 14.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.07%
Mar 31, 2026 8.71%
Dec 31, 2025 -19.48%
Sep 30, 2025 -37.76%
Jun 30, 2025 -25.43%
Mar 31, 2025 9.89%
Dec 31, 2024 25.19%
Sep 30, 2024 1.99%
Jun 30, 2024 -26.97%
Mar 31, 2024 -12.86%
Dec 31, 2023 -21.95%
Sep 30, 2023 -11.60%
Jun 30, 2023 -119.23%
Mar 31, 2023 -9.44%
Dec 31, 2022 -20.34%
Sep 30, 2022 -43.97%
Jun 30, 2022 -122.89%
Mar 31, 2022 -181.55%
Dec 31, 2021 -196.56%
Sep 30, 2021 -5,462.49%
API Access

Regenerative Medical Technology Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RMTG&period=max&api_key=YOUR_API_KEY